Carboplatin can cause a decrease in the number of blood cells in your bone marrow. Your doctor will order tests before, during, and after your treatment to see if your blood cells are affected by this drug.
Your doctor has ordered the drug carboplatin to help treat your illness. The drug is given by injection into a vein.
ovarian carcinoma
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Carboplatin is in a class of drugs known as platinum-containing compounds; it slows or stops the growth of cancer cells in your body. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.
Carboplatin also is used to treat certain types of lung cancer, testicular cancer, head and neck cancer, Wilms' tumor, brain tumors, bladder cancer, and retinoblastoma. Talk to your doctor about the possible risks of using this drug for your condition.
thinned or brittle hair
loss of appetite or weight
stomach pain
diarrhea
constipation
nausea and vomiting
changes in taste
changes in vision
numbness or tingling in the fingertips
mouth blistering
fatigue
red urine
unusual bruising or bleeding
black, tarry stools
fever
chills
dizziness or feeling of faintness
pain in your side or back
shortness of breath or wheezing
swelling of the feet or ankles
rash
hearing loss
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/Safety/MedWatch] or by phone [1-800-332-1088].
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Last Reviewed - 09/01/2010
AHFS® Consumer Medication Information. © Copyright, 2012. The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.